ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Role of depressive symptoms in cardiometabolic diseases and subsequent transitions to all-cause mortality: an application of multistate models in a prospective cohort study

Qiao, Yanan; Liu, Siyuan; Li, Guochen; Lu, Yanqiang; Wu, Ying; Ding, Yi*; Ke, Chaofu*南方医科大学; 苏州大学; y
STROKE AND VASCULAR NEUROLOGY2021-12DOI: 10.1136/svn-2020-000693
13被引6阅读
引用收藏
分享

摘要

Background and purpose The role of depression in the development and outcome of cardiometabolic diseases remains to be clarified. We aimed to examine the extent to which depressive symptoms affect the transitions from healthy to diabetes, stroke, heart disease and subsequent all-cause mortality in a middle-aged and elderly European population. Methods A total of 78 212 individuals aged >= 50 years from the Survey of Health Ageing and Retirement in Europe were included. Participants with any baseline cardiometabolic diseases including diabetes, stroke and heart disease were excluded. Depressive symptoms were measured by the Euro-Depression scale at baseline. Participants were followed up to determine the occurrence of cardiometabolic diseases and all-cause mortality. We used multistate models to estimate the transition-specific HRs and 95% CIs after adjustment of confounders. Results During 500 711 person-years of follow-up, 4742 participants developed diabetes, 2173 had stroke, 5487 developed heart disease and 7182 died. Depressive symptoms were significantly associated with transitions from healthy to diabetes (HR: 1.12, 95% CI: 1.05 to 1.20), stroke (HR: 1.31, 95% CI: 1.18 to 1.44), heart disease (HR: 1.26, 95% CI: 1.18 to 1.34) and all-cause mortality (HR: 1.41, 95% CI: 1.34 to 1.49). After cardiometabolic diseases, depressive symptoms were associated with the increased risk of all-cause mortality in patients with diabetes (HR: 1.54, 95% CI: 1.25 to 1.89), patients who had stroke (HR: 1.29, 95% CI: 1.03 to 1.61) and patients with heart disease (HR: 1.21, 95% CI: 1.02 to 1.44). Conclusions Depressive symptoms increase the risk of diabetes, stroke and heart disease, and affect the risk of mortality after the onset of these cardiometabolic conditions. Screening and treatment of depressive symptoms may have profound implications for the prevention and prognosis of cardiometabolic diseases.

学科与关键词

关键词
stroke
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
STROKE AND VASCULAR NEUROLOGY
发表日期
2021-12
卷期
第 6 卷, 第 4 期
页码
511-518
DOI
10.1136/svn-2020-000693
成果收录
SSCI · SCIE
资助标注
National Natural Science Foundation of China [81703316]; Natural Science Foundation of Jiangsu Province [BK20170350]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Natural Science Research Projects of Colleges and Universities in Jiangsu Province [20KJB330004]

作者

  • Q

    Qiao, Yanan (第一作者)

    soochow univ

  • L

    Liu, Siyuan

    soochow univ

查看全部 7 位作者收起作者
  • L

    Li, Guochen

    soochow univ

  • L

    Lu, Yanqiang

    soochow univ

  • W

    Wu, Ying

    southern med univ

  • D

    Ding, Yi (通讯)

  • K

    Ke, Chaofu (通讯)

    soochow univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417